Часть 33 из 49 В начало
Для доступа к библиотеке пройдите авторизацию
35
24. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol 2001; 98(5 Pt 1): 806–14.
36
25. Duckitt K, Collins S. Menorrhagia. BMJ Clin Evid 2008; 2008.
37
25. Duckitt K, Collins S. Menorrhagia. BMJ Clin Evid 2008; 2008.
38
26. Zahradnik HP, Hanjalic-Beck A, Groth K. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review. Contraception 2010; 81(3): 185–96.
39
27. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2015; (7): CD001751.
40
28. Dehnavi ZM, Jafarnejad F, Kamali Z. The Effect of aerobic exercise on primary dysmenorrhea: A clinical trial study. J Educ Health Promot 2018; 7: 3.
41
29. Kikuchi H, Nakatani Y, Seki Y, et al. Decreased blood serotonin in the premenstrual phase enhances negative mood in healthy women. J Psychosom Obstet Gynaecol 2010; 31(2): 83–9.
42
30. Lanza di Scalea T, Pearlstein T. Premenstrual Dysphoric Disorder. Psychiatr Clin North Am 2017; 40(2): 201–16.
43
30. Lanza di Scalea T, Pearlstein T. Premenstrual Dysphoric Disorder. Psychiatr Clin North Am 2017; 40(2): 201–16.
44
31. Pennant ME, Mehta R, Moody P, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG 2017; 124(3): 404–11.
45
31. Pennant ME, Mehta R, Moody P, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG 2017; 124(3): 404–11.
46
32. Pattanittum P, Kunyanone N, Brown J, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev 2016; 3: CD002124.
47
book-ads2